This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Dawanne E Poree: Innovator in Atherosclerosis Treatment
Introduction
Dawanne E Poree is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of medical science, particularly in the treatment of atherosclerosis. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Dawanne E Poree holds a patent for "Macromolecules for treating atherosclerosis." This invention includes compounds of the formula I and formula II, along with their salts, and outlines methods for utilizing these compounds in the treatment of atherosclerosis. Additionally, the patent encompasses compounds of formula III and (2l), as well as methods for their application in treating the same condition. The invention also details methods for encapsulating molecules using the compounds developed.
Career Highlights
Dawanne E Poree is affiliated with Rutgers, the State University of New Jersey, where he continues to contribute to research and innovation in his field. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Some of his notable coworkers include Kathryn Elizabeth Uhrich and Prabhas V Moghe. Their collaborative efforts have further enhanced the research and development of innovative solutions in medical science.
Conclusion
Dawanne E Poree's contributions to the treatment of atherosclerosis through his patented inventions highlight his role as a significant innovator in the medical field. His work continues to inspire advancements in healthcare and treatment methodologies.